SiBionics announced today that it unveiled its GS3 continuous glucose monitor (CGM), which now has CE mark approval.

Sales of Beta Bionics insulin pumps spiked 145% in the fourth quarter behind solid new patient starts. Elsewhere, former ...

With its ultra-compact design and 3-second activation, GS3 quickly became a highlight at ATTD 2025 with its revolutionary ...

It offers: At ATTD 2025, SIBIONICS hosted the SIBIONICS Symposium, where experts shared research findings on the clinical applications of CGM and the differentiation of AGP (Ambulatory Glucose ...

SIBIONICS participated in this prestigious event, unveiling the world's thinnest CGM device—GS3, showcasing its latest breakthrough in glucose monitoring technology. SIBIONICS GS3 Achieves CE ...